Testing a hormone supplement to improve heart and metabolic health
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether adding a natriuretic peptide medicine improves heart health and metabolism in Black adults. It may help with blood pressure and related health markers, but you must meet specific health and safety criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Identify as African-American or Black
- Have blood pressure between 120–160 on the top number and 80–100 on the bottom number
- Avoid pregnancy and follow birth control rules if you could become pregnant
- Do not have a history of heart or blood-vessel problems like stroke, heart attack, heart failure, or certain heart rhythm issues
- Be able to safely walk/run on a treadmill for the study testing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether timing blood pressure medications (based on your natural daily body rhythms) can improve blood pressure control. It’s designed for adults with moderately high blood pressure and focuses on who may benefit from a more precise schedule.
This study tests whether a new medication can improve heart and metabolic health (like blood pressure and blood sugar control) in Black adults with obesity and high blood pressure. It aims to reduce risk of diabetes and heart disease.
This study looks at how genetic markers (DNA) relate to heart health and “metabolic” health (how your body manages sugar and fat). You may be asked to provide genetic samples and follow study health checks and protocols to help researchers understand who is at higher risk.
This trial tests a new approach to improve blood flow in the hearts of women with HIV who also have diabetes or kidney problems. It might help prevent heart disease in this population.
This trial tests whether a combination of two blood pressure drugs (sacubitril/valsartan) is better than one drug alone (valsartan) at improving heart function in people with high blood pressure. It may help reduce strain on the heart's upper chambers.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.